タンパク質治療薬の開発への注目の高まり、組換えタンパク質薬の継続的な革新、および抗体ベースの薬の成長により、タンパク質の研究が増加しています。タンパク質工学。治療用タンパク質およびペプチドは、癌、神経変性疾患などのさまざまな疾患の治療に大きな可能性があることも確認されています。ただし、タンパク質の物理化学的不安定性と免疫原性の懸念により、予測期間にわたって世界のタンパク質治療薬市場が抑制される可能性があります。
「2031年までの世界のタンパク質治療薬市場分析」は、タンパク質治療薬の世界の専門的かつ詳細な調査です。世界の市場動向に焦点を当てたバイオテクノロジー産業。このレポートは、製品、アプリケーション、エンドユーザー、地域ごとに詳細な市場分割を行い、世界市場の概要を提供することを目的としています。世界のタンパク質治療市場は、予測期間中に高い成長を遂げると予想されます。このレポートは、タンパク質治療薬市場の主要プレーヤーの市場状況に関する主要な統計を提供し、市場の主要な傾向と機会を提供します。
世界のタンパク質治療薬市場は、製品、アプリケーション、最終目的に基づいて分割されています。ユーザー。製品に基づいて、市場はモノクローナル抗体、インスリン、融合タンパク質、エリスロポエチン、インターフェロン、ヒト成長ホルモン、卵胞刺激ホルモンに分類されます。タンパク質治療薬市場は用途別に、代謝疾患、免疫疾患、血液疾患、がん、ホルモン疾患、遺伝疾患などに分類されます。エンドユーザーに基づいて、タンパク質治療薬市場は製薬会社、ヘルスケアサービスプロバイダー、研究機関、および医療機関に分類されます。学術研究機関。
このレポートは、定性的情報と定量的情報の両方を含む業界の詳細な概要を提供します。製品、アプリケーション、エンドユーザーに基づいた世界のタンパク質治療薬市場の概要と予測を提供します。また、次の 5 つの主要地域に関する市場全体の市場規模と 2031 年までの予測も提供します。北米、ヨーロッパ、アジア太平洋 (APAC)、中東およびアフリカ (MEA)、南および南。中米。各地域ごとのタンパク質治療薬市場は、後でそれぞれの国とセグメントごとにサブセグメント化されます。このレポートでは、世界 13 か国の分析と予測、およびこの地域に広がっている現在の傾向と機会について取り上げています。
2021 年のタンパク質治療薬市場では、北米が圧倒的なシェアを占めました。主要なシェアは技術の進歩によるものと考えられます。 、有利な償還政策、新製品の開発、生活水準の向上により平均寿命が延び、高齢者人口の増加に貢献しています。これらの要因により、この地域におけるタンパク質治療薬の成長が促進されています。
アジア太平洋地域は、糖尿病などの慢性疾患の有病率が高いため、予測期間中に最高のCAGRを示すと予想されます。また、アジア太平洋地域における医療観光産業の成長も、予測期間中にタンパク質治療薬市場の市場需要を促進すると予想される主要な要因です。さらに、高度な治療オプションに対する需要の高まり、中国、インド、日本などの新興経済、1人当たり収入の増加などの要因により、予測期間中にアジア太平洋地域の市場プレーヤーに成長の道が生まれると予想されます。
レポートは、需要側と供給側の両方からタンパク質治療薬市場に影響を与える要因を分析し、予測期間中に市場に影響を与える市場ダイナミクス、つまり推進力、制約、機会、将来の傾向をさらに評価します。このレポートは、5 つの地域すべてに対する徹底的な PEST 分析も提供します。北米、ヨーロッパ、APAC、MEA、南および南。これらの地域のタンパク質治療薬市場に影響を与える政治的、経済的、社会的、技術的要因を評価した後、中央アメリカ。
レポートには、主要なタンパク質治療薬企業のプロフィールとSWOT分析および市場戦略も含まれています。さらに、このレポートは、企業概要、提供されるコンポーネントとサービス、過去 3 年間の財務情報、過去 5 年間の主な開発などの情報を含む業界の主要企業に焦点を当てています。タンパク質治療薬市場で活動している主要企業には、Novo Nordisk A/S、Janssen Global Services, LLC (Johnson & Johnson Services, Inc.)、Amgen Inc.、AstraZeneca、Baxter、Boehringer Ingelheim International GmbH、Teva Pharmaceutical Industries が含まれます。 Ltd.、協和発酵キリン株式会社、ファイザー株式会社、F.ホフマン・ラ・ロッシュ株式会社など。
.
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
Key companies in this market are - Novo Nordisk A/S, Janssen Global Services LLC, Johnson & Johnson Services Inc, Amgen Inc, AstraZeneca, Baxter, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd, Kyowa Hakko Kirin Co Ltd, Pfizer Inc
The Protein Therapeutics Market is expected to witness a shift towards personalised medicine with enormous focus on tailored therapy. Innovative therapeutic proteins, better drug design and advancement in protein engineering would deliver enhanced efficacy, addressing specific patient need and expanding market applications.
The market is expected to register a CAGR of 6.5% during 2023-2031
Fueling the growth of the Protein Therapeutics Market is the rising incidence of chronic diseases, and the growing need for biologic therapeutics. Also, the rising demand for protein-based therapies is due to the rising acceptance of biological therapies, global efforts to cure chronic diseases, and scientific advancements in protein engineering and manufacturing.
Trends and growth analysis reports related to Life Sciences : READ MORE..
1. Novo Nordisk A/S
2. Janssen Global Services, LLC (Johnson & Johnson Services, Inc.)
3. Amgen Inc.
4. AstraZeneca
5. Baxter
6. Boehringer Ingelheim International GmbH
7. Teva Pharmaceutical Industries Ltd.
8. Kyowa Hakko Kirin Co., Ltd.
9. Pfizer Inc.
10. F. Hoffmann-La Roche Ltd
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.